Filters

Category: Newsletter

Nasdaq Adopts Emergency Temporary Relief Due to the Spread of COVID-19

04.23.2020
Michael A. GoldsteinSamantha A. Lesser

As a result of the market uncertainty unleashed by the COVID-19 crisis, the Nasdaq Stock Market (“Nasdaq”) has seen an increased number of issuers become non-compliant with its continued listing requirements for maintaining a minimum bid price and the market value of publicly-held shares (hereinafter “Price Requirements”). On April 17, […]

Areas of Focus: Business Litigation, Corporate

Senate Passes “Phase 3.5” Coronavirus Relief Package

04.22.2020
Omar Franco

As predicted, the Senate has officially passed the latest Coronavirus relief package. The Paycheck Protection Program and Health Care Enhancement Act, colloquially referred to as “Phase 3.5” or “CARES Act II,” will contribute just under half a trillion dollars for critical economic and public health initiatives. The $484 billion legislation […]

Areas of Focus: Federal Lobbying, Government Law & Lobbying

Washington Update: April 21

04.21.2020
Omar Franco

Late night negotiations between House Speaker Nancy Pelosi, Senate Democratic Leader Chuck Schumer, Treasury Secretary Steve Mnuchin, and White House Chief of Staff Mark Meadows on legislation replenishing the funds for the Paycheck Protection Program (PPP) have been productive. By nearly all accounts, a deal approaching nearly half a trillion […]

Areas of Focus: Federal Lobbying, Government Law & Lobbying

Recent SEC Actions in the Wake of COVID-19

04.17.2020
Michael A. GoldsteinSamantha A. Lesser

In light of the unprecedented disruptions associated with COVID-19, the U.S. Securities and Exchange Commission (the “SEC”) has recently released a number of public statements providing advice and regulatory relief to public companies due to the impact of COVID-19. NYSE Waiver of Shareholder Approval Requirements In an measure to provide […]

Areas of Focus: Corporate